High, P.; Guernsey, C.; Subramanian, S.; Jacob, J.; Carmon, K.S.
The Evolving Paradigm of Antibody–Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases. Pharmaceutics 2024, 16, 890.
https://doi.org/10.3390/pharmaceutics16070890
AMA Style
High P, Guernsey C, Subramanian S, Jacob J, Carmon KS.
The Evolving Paradigm of Antibody–Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases. Pharmaceutics. 2024; 16(7):890.
https://doi.org/10.3390/pharmaceutics16070890
Chicago/Turabian Style
High, Peyton, Cara Guernsey, Shraddha Subramanian, Joan Jacob, and Kendra S. Carmon.
2024. "The Evolving Paradigm of Antibody–Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases" Pharmaceutics 16, no. 7: 890.
https://doi.org/10.3390/pharmaceutics16070890
APA Style
High, P., Guernsey, C., Subramanian, S., Jacob, J., & Carmon, K. S.
(2024). The Evolving Paradigm of Antibody–Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases. Pharmaceutics, 16(7), 890.
https://doi.org/10.3390/pharmaceutics16070890